Basetwo AI’s cover photo
Basetwo AI

Basetwo AI

Software Development

Toronto, Ontario 12,904 followers

AI Engineered for Manufacturing

About us

Basetwo is a venture-backed AI company helping pharma, specialty chemical, and cosmetics manufacturers bring products to full-scale production faster and with less risk. We give manufacturers a “digital twin” of their production process - a virtual replica that lets them simulate, test, and optimize manufacturing before running it in the real world. Instead of learning through costly mistakes on the plant floor, teams can predict performance, de-risk scale-up, and standardize tech transfer in advance. Basetwo is already deployed with leading global pharmaceutical, specialty chemical, and personal care manufacturers. We’re building the AI layer for manufacturing process development, scale-up and quality control - turning one of the slowest, riskiest parts of manufacturing into a predictable, data-driven process.

Website
https://www.basetwo.ai/
Industry
Software Development
Company size
11-50 employees
Headquarters
Toronto, Ontario
Type
Privately Held
Specialties
Machine Learning, Simulation, Process Control, Process Optimization, Digital Twin, Pharmaceuticals, Industry 4.0, Chemicals, Manufacturing, Batteries, AI, Cosmetics Manufacturing, Specialty Chemicals, Scale up, Development, and Tech transfer

Locations

Employees at Basetwo AI

Updates

  • 1 day until we go live ⏰ Last chance to register! Join Basetwo and Eric Will Doerr, MESc., P.Eng., Head of Pilot-Scale (MSAT) Labs, Canada at Sanofi, for a live discussion on moving bioprocesses from development and pilot scale to commercial manufacturing. It will be an engaging conversation on scale-up, how to preserve process understanding across scales, and where modeling, AI, and digital twins can support more scaleable process. 📅 Sep 24 @ 10:00 AM ET 🔗 Register here: https://lnkd.in/d_tdKuzZ

    • No alternative text description for this image
  • That’s a wrap on World Adhesive & Sealant Conference in London 🇬🇧 Our CEO & Co-Founder, Thouheed Abdul Gaffoor, took the stage and shared a real-world look at predictive digital twins in polymer and adhesive manufacturing. It was great to spend the week exchanging ideas with leaders across the industry and hearing how manufacturers are approaching quality, process control, and scale-up. Thanks to everyone who joined our session or connected with the Basetwo team at #WAC2026. See you next time! 👋

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • The Basetwo team is heading to Princeton and Boston for two industry events next week. From continuous manufacturing and real-time CQA prediction to digital twins for predictive process monitoring, we’re looking forward to sharing some of the work we’ve been doing across pharmaceutical manufacturing and hearing what others are working on! 📍 Sep 22–23 · Princeton — Continuous Manufacturing Forum 📍 Sep 22–25 · Boston — BPI US Heading to either? Let's connect! #BPIUS #CMF2026

  • We're heading to London next week for the World Adhesive & Sealant Conference (#WAC2026) 🇬🇧 If you're attending, don't miss Thouheed Abdul Gaffoor's session on September 18 at 11:30 AM BST. He'll be sharing how predictive digital twins can unlock faster quality insights and more proactive process control for polymer and adhesive manufacturers. Looking forward to connecting with everyone at WAC 2026!

    • Basetwo at World Adhesive & Sealant Conference and Expo
  • Where can AI actually make a difference in scaling up bioprocesses? Scale-up is about more than increasing volume. It’s about carrying process understanding forward, making better decisions with the data you have, and knowing where new tools like modeling and AI can actually add value. On September 24, we’re sitting down with Eric Will Doerr, MESc., P.Eng. from Sanofi to talk scale-up, process understanding, modeling, and where AI and digital twins can have the biggest impact. 🧬 September 24 | 10 AM ET Register today and save your spot!!

  • We’re heading to #ACSFall2026, where we’ll be sharing our work on a challenge that continues to shape formulation and process development: making scale-up more predictable. For complex polymeric and colloidal systems, scaling up isn’t simply about making a bigger batch. Changes in mixing, shear, and hydrodynamics can fundamentally change product behaviour. In our talk on Aug 24, we'll be discussing how physics-informed digital twins can make scale-up more predictable. If you’re heading to ACS, we’d love to connect! American Chemical Society | Emma McGlade | Trevor Murray

    • No alternative text description for this image
  • We'll be in two places at once ‼️ Looking forward to an exciting couple of weeks ahead as the Basetwo team heads to Bioprocessing Summit and Lab Ops from August 10-13. The conversation around AI in bioprocessing is evolving quickly. We're looking forward to discussing what's working today, and what's next for biomanufacturing. If you're attending either event, let us know - we'd love to connect!

    • No alternative text description for this image
  • What if AI assistants could do more than answer questions about your data? Agentic AI represents a new approach, helping teams automate complex workflows from data preparation to analysis and modeling. Unlike traditional biologics, gene therapies often rely on limited batch data and highly variable processes, making development and scale-up especially challenging. Join Basetwo in our latest webinar as we discuss how agentic workflows can help accelerate gene therapy process development and de-risk manufacturing. We'll showcase how to streamline data transformation, analysis, modeling, and monitoring with agentic workflows. 📅: August 18, 2026 ⏰: 11am ET Secure your spot today!

Similar pages

Browse jobs